|
|
We report three patients(age 37052 years)with acute respiratory insufficiency who developed prolonged weakness following the discontinuation of ND-NMBAs.The weakness in these patients is due to pathology at both the neuromuscular junction(most likely due to ND-NMBA) and muscle(most likely due to corticosteroids).Hepatic dysfunction and acidosis are contributing risk factors. |
|